Neurogene
Wei Liao has extensive work experience in research roles. Their most recent position was as a Research Scientist at Neurogene Inc., starting in October 2019. Prior to this, they worked at Mesoblast Limited as a Research Scientist from February 2014 to October 2019. They also held a position as a Research Associate at the Center for Stem Cell Research, Institute of Molecular Medicine (IMM) from August 2010 to February 2014. Before that, they worked as a Research Associate at the Texas Institute for Genomic Medicine from May 2007 to July 2010. Wei Liao also has experience as a Senior Research Assistant at the Laboratory for Developmental Biology (LDB), Institute of Molecular Medicine (IMM) from October 2002 to April 2007. Their career began as an Assistant Engineer at Shanghai Meiyou Pharmaceutical Co., Ltd from June 1994 to July 1998.
Wei Liao has a Bachelor of Engineering degree from the Department of Fine at East China University of Science and Technology. Their field of study included Chemical Engineering and Chemical Pharmaceutics. No specific start or end year was provided.
This person is not in any offices
Neurogene
Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring to patients therapies that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy.